Acute mountain sickness: pathophysiology, prevention, and treatment.

Barometric pressure falls with increasing altitude and consequently there is a reduction in the partial pressure of oxygen resulting in a hypoxic challenge to any individual ascending to altitude. A spectrum of high altitude illnesses can occur when the hypoxic stress outstrips the subject's ability to acclimatize. Acute altitude-related problems consist of the common syndrome of acute mountain sickness, which is relatively benign and usually self-limiting, and the rarer, more serious syndromes of high-altitude cerebral edema and high-altitude pulmonary edema. A common feature of acute altitude illness is rapid ascent by otherwise fit individuals to altitudes above 3000 m without sufficient time to acclimatize. The susceptibility of an individual to high-altitude syndromes is variable but generally reproducible. Prevention of altitude-related illness by slow ascent is the best approach, but this is not always practical. The immediate management of serious illness requires oxygen (if available) and descent of more than 300 m as soon as possible. In this article, we describe the setting and clinical features of acute mountain sickness and high-altitude cerebral edema, including an overview of the known pathophysiology, and explain contemporary practices for both prevention and treatment exploring the comprehensive evidence base for the various interventions.

[1]  J. P. Hannon,et al.  Effects of acute high-altitude exposure on body fluids. , 1969, Federation proceedings.

[2]  R. Panerai,et al.  Acute hypoxia impairs dynamic cerebral autoregulation: results from two independent techniques. , 2009, Journal of applied physiology.

[3]  P. Wagner,et al.  Effect of acetazolamide on pulmonary and muscle gas exchange during normoxic and hypoxic exercise , 2007, The Journal of physiology.

[4]  G. Kamimori,et al.  Improvement in hypoxemia at 4600 meters of simulated altitude with carbohydrate ingestion. , 1999, Aviation, space, and environmental medicine.

[5]  J. Serra,et al.  Ginkgo biloba Decreases Acute Mountain Sickness in People Ascending to High Altitude at Ollagüe (3696 m) in Northern Chile , 2007, Wilderness & environmental medicine.

[6]  R. Roach,et al.  Acute ventilatory response to simulated altitude, normobaric hypoxia, and hypobaria. , 1996, Aviation, space, and environmental medicine.

[7]  U. Scherrer,et al.  Effects of high-altitude exposure on vascular endothelial growth factor levels in man , 2001, European Journal of Applied Physiology.

[8]  M. Yaron,et al.  How well do older persons tolerate moderate altitude? , 1995, The Western journal of medicine.

[9]  B. Stone,et al.  Altitude insomnia: studies during an expedition to the Himalayas. , 1988, Sleep.

[10]  B. Levine,et al.  Effect of hypoxic "dose" on physiological responses and sea-level performance. , 2007, Medicine and science in sports and exercise.

[11]  M. Hamlin,et al.  Game performance and intermittent hypoxic training , 2007, British Journal of Sports Medicine.

[12]  L. Moore,et al.  Acute Mountain Sickness in a General Tourist Population at Moderate Altitudes , 1993, Annals of Internal Medicine.

[13]  R. Ross THE RANDOM NATURE OF CEREBRAL MOUNTAIN SICKNESS , 1985, The Lancet.

[14]  P. Chase,et al.  Obesity: Associations with Acute Mountain Sickness , 2003, Annals of Internal Medicine.

[15]  M. Serrano-Dueñas High Altitude Headache. A Prospective Study of its Clinical Characteristics , 2005, Cephalalgia : an international journal of headache.

[16]  V. M. Sharma,et al.  Amelioration of acute mountain sickness: Comparative study of acetazolamide and spironolactone , 1986, International journal of biometeorology.

[17]  R. Koehler,et al.  6 – Neural Control of the Circulation during Hypoxia , 1980 .

[18]  T. Seto,et al.  Ginkgo biloba for the prevention of severe acute mountain sickness (AMS) starting one day before rapid ascent. , 2002, High altitude medicine & biology.

[19]  G. Skrinar,et al.  Seven intermittent exposures to altitude improves exercise performance at 4300 m. , 2008, Medicine and science in sports and exercise.

[20]  P. Hackett The cerebral etiology of high-altitude cerebral edema and acute mountain sickness , 1999, Wilderness & environmental medicine.

[21]  P. Goadsby PATHOPHYSIOLOGY OF MIGRAINE , 2006, Neurologic clinics.

[22]  W. Mills,et al.  Dexamethasone for prevention and treatment of acute mountain sickness. , 1988, Aviation Space and Environmental Medicine.

[23]  J. Jensen,et al.  Cerebral Blood Flow Does Not Adapt to Sustained Hypoxia , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[24]  Mark H. Wilson,et al.  DIRECT MEASUREMENT OF INTRACRANIAL PRESSURE AT HIGH ALTITUDE AND CORRELATION OF VENTRICULAR SIZE WITH ACUTE MOUNTAIN SICKNESS: BRIAN CUMMINS' RESULTS FROM THE 1985 KISHTWAR EXPEDITION , 2008, Neurosurgery.

[25]  J. Severinghaus Hypothetical roles of angiogenesis, osmotic swelling, and ischemia in high-altitude cerebral edema. , 1995, Journal of applied physiology.

[26]  Kevin Giblin,et al.  Acute mountain sickness in a general tourist population at moderate altitudes , 1993 .

[27]  Allen Cymerman,et al.  Intermittent altitude exposures reduce acute mountain sickness at 4300 m. , 2004, Clinical science.

[28]  P. Hackett,et al.  Acetazolamide in the Treatment of Acute Mountain Sickness: Clinical Efficacy and Effect on Gas Exchange , 1992, Annals of Internal Medicine.

[29]  B. Kayser,et al.  Magnesium for the prevention and treatment of acute mountain sickness. , 2004, Clinical science.

[30]  M. Tramèr,et al.  Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review , 2000, BMJ : British Medical Journal.

[31]  B. Tufts,et al.  The structure and function of carbonic anhydrase isozymes in the respiratory system of vertebrates , 2006, Respiratory Physiology & Neurobiology.

[32]  L. Garske,et al.  Acetazolamide reduces exercise capacity and increases leg fatigue under hypoxic conditions. , 2003, Journal of applied physiology.

[33]  M. Serrano-Dueñas High-altitude headache , 2007, Expert review of neurotherapeutics.

[34]  E. Ringelstein,et al.  Relationship of cerebral blood flow regulation to acute mountain sickness. , 1989, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[35]  W. Brechue,et al.  Normoxic and acute hypoxic exercise tolerance in man following acetazolamide. , 1990, Medicine and science in sports and exercise.

[36]  J. Milledge,et al.  High altitude headache: treatment with ibuprofen. , 1994, Aviation, space, and environmental medicine.

[37]  C. Peterson Acetazolamide in the treatment of acute mountain sickness: Clinical efficacy and effect on gas exchange: Grissom CK, Roach RC, Sarnquist FH, et al Ann Intern Med 116:461–465 Mar 1992 , 1992 .

[38]  T. H. Bavenhill Some Experiences of Mountain Sickness in the Andes. , 1913 .

[39]  T. Balkin,et al.  Effect of high terrestrial altitude and supplemental oxygen on human performance and mood. , 1992, Aviation, space, and environmental medicine.

[40]  B. Levine,et al.  Dexamethasone in the treatment of acute mountain sickness. , 1989, The New England journal of medicine.

[41]  M. Yaron,et al.  Treatment of acute mountain sickness: hyperbaric versus oxygen therapy. , 1991, Annals of emergency medicine.

[42]  F Lofaso,et al.  Effect of zolpidem on sleep and ventilatory patterns at simulated altitude of 4,000 meters. , 1996, American journal of respiratory and critical care medicine.

[43]  A. Cymerman,et al.  The effect of altitude pre-acclimatization on acute mountain sickness during reexposure. , 1995, Aviation, space, and environmental medicine.

[44]  M. MacDougall,et al.  Change in plasma vascular endothelial growth factor during onset and recovery from acute mountain sickness. , 2007, Respiratory medicine.

[45]  E. Swenson,et al.  Prevention of acute mountain sickness by acetazolamide: as yet an unfinished story. , 2007, Journal of applied physiology.

[46]  Effect of magnesium, high altitude and acute mountain sickness on blood flow velocity in the middle cerebral artery. , 2004, Clinical science.

[47]  A. Bradwell,et al.  Carbonic anhydrase inhibition in the immediate therapy of acute mountain sickness , 1994 .

[48]  P. Sonnenberg,et al.  Clinical features of headache at altitude , 2003, Neurology.

[49]  K. Bloch,et al.  Both Tadalafil and Dexamethasone May Reduce the Incidence of High-Altitude Pulmonary Edema , 2006, Annals of Internal Medicine.

[50]  P. Boesiger,et al.  Hypoxia-Induced Acute Mountain Sickness is Associated with Intracellular Cerebral Edema: A 3 T Magnetic Resonance Imaging Study , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[51]  A. Bradwell,et al.  Methazolamide and acetazolamide in acute mountain sickness. , 1983, Aviation Space and Environmental Medicine.

[52]  J. West Improving oxygenation at high altitude: acclimatization and O2 enrichment. , 2003, High altitude medicine & biology.

[53]  P. Hackett,et al.  High altitude cerebral edema. , 2004, High altitude medicine & biology.

[54]  P. Bärtsch,et al.  Ataxia in acute mountain sickness does not improve with short-term oxygen inhalation. , 2002, High altitude medicine & biology.

[55]  W. Haefeli,et al.  Cytochrome P450 enzyme-mediated drug metabolism at exposure to acute hypoxia (corresponding to an altitude of 4,500 m) , 2005, European Journal of Clinical Pharmacology.

[56]  J. Stradling,et al.  Temazepam at high altitude reduces periodic breathing without impairing next‐day performance: a randomized cross‐over double‐blind study , 2006, Journal of sleep research.

[57]  A-K Dubey,et al.  Ginkgo biloba--an appraisal. , 2004, Kathmandu University medical journal.

[58]  Forster Pj Effect of different ascent profiles on performance at 4,200 m elevation. , 1985 .

[59]  D. Subedi,et al.  Prevention of Acute Mountain Sickness by Acetazolamide in Nepali Porters: A Double-Blind Controlled Trial , 2006, Wilderness & environmental medicine.

[60]  Charles D. Barnes,et al.  Neural control of circulation , 1980 .

[61]  Thomas G. Smith,et al.  Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials. , 2009, JAMA.

[62]  C. Sartori,et al.  New insights in the pathogenesis of high-altitude pulmonary edema. , 2010, Progress in cardiovascular diseases.

[63]  K. Bloch,et al.  Effect of ascent protocol on acute mountain sickness and success at Muztagh Ata, 7546 m. , 2009, High altitude medicine & biology.

[64]  M. Manyak,et al.  High-Altitude Medicine , 2019, Travel Medicine.

[65]  Charles S. Houston,et al.  THE LAKE-LOUISE ACUTE MOUNTAIN-SICKNESS SCORING SYSTEM , 1993 .

[66]  J. Remmers,et al.  Hypoxia: The Adaptations , 1988 .

[67]  S. Teng,et al.  Animal Models of Acute Moderate Hypoxia Are Associated with a Down-Regulation of CYP1A1, 1A2, 2B4, 2C5, and 2C16 and Up-Regulation of CYP3A6 and P-glycoprotein in Liver , 2007, Drug Metabolism and Disposition.

[68]  P. D'arbigny,et al.  EGb 761 in control of acute mountain sickness and vascular reactivity to cold exposure. , 1996, Aviation, space, and environmental medicine.

[69]  G. Skrinar,et al.  Intermittent altitude exposures improve muscular performance at 4,300 m. , 2003, Journal of applied physiology.

[70]  A. Cymerman,et al.  The Effects of Propranolol on Acute Mountain Sickness (AMS) and Well- Being at 4300 Meters Altitude , 1989 .

[71]  Bernhard Wn,et al.  Acetazolamide plus low-dose dexamethasone is better than acetazolamide alone to ameliorate symptoms of acute mountain sickness. , 1998 .

[72]  A. Roessler,et al.  Role of hypobaria in fluid balance response to hypoxia. , 2005, High altitude medicine & biology.

[73]  Scott A Gallagher,et al.  High-altitude illness. , 2001, The New England journal of medicine.

[74]  P. Lichter Reducing side effects of carbonic anhydrase inhibitors. , 1981, Ophthalmology.

[75]  E. Swenson,et al.  Acute mountain sickness is not altered by a high carbohydrate diet nor associated with elevated circulating cytokines. , 1997, Aviation, space, and environmental medicine.

[76]  A. Pollard ALTITUDE INDUCED ILLNESS : IF IN DOUBT GO DOWN , 1992 .

[77]  W. Nachbauer,et al.  Effects of Aspirin During Exercise on the Incidence of High‐Altitude Headache: A Randomized, Double‐Blind, Placebo‐Controlled Trial , 2001, Headache.

[78]  P. Golja,et al.  Carbohydrate ingestion improves oxygen delivery in acute hypoxia. , 2008, High altitude medicine & biology.

[79]  E. Swenson Carbonic anhydrase inhibitors and hypoxic pulmonary vasoconstriction , 2006, Respiratory Physiology & Neurobiology.

[80]  P. Bärtsch,et al.  Determinants of acute mountain sickness and success on Mount Aconcagua (6962 m). , 2005, High altitude medicine & biology.

[81]  T. Maren,et al.  The activity of sulfonamides and anions against the carbonic anhydrases of animals, plants, and bacteria. , 1983, Annual review of pharmacology and toxicology.

[82]  J. Krasney A neurogenic basis for acute altitude illness. , 1994, Medicine and science in sports and exercise.

[83]  P. Hackett,et al.  Frontiers of hypoxia research: acute mountain sickness. , 2001, The Journal of experimental biology.

[84]  B. Kayser,et al.  Reduced incidence and severity of acute mountain sickness in Qinghai-Tibet railroad construction workers after repeated 7-month exposures despite 5-month low altitude periods. , 2009, High altitude medicine & biology.

[85]  Mo Amdur Effects of inhalation of sulfur dioxide by man , 1953 .

[86]  K. Kubo,et al.  Low pulmonary diffusing capacity in subjects with acute mountain sickness. , 1997, Chest.

[87]  P. Hackett,et al.  Ginkgo biloba for prevention of acute mountain sickness: does it work? , 2009, High altitude medicine & biology.

[88]  E. Swenson,et al.  Hypoxic ventilatory response, ventilation, gas exchange, and fluid balance in acute mountain sickness. , 2002, High altitude medicine & biology.

[89]  P. Hackett,et al.  ACUTE MOUNTAIN SICKNESS , 1977, The Lancet.

[90]  J. Bittel,et al.  Positive end expiratory pressure as a method for preventing acute mountain sickness , 1997, European Journal of Applied Physiology and Occupational Physiology.

[91]  M. Raichle,et al.  EFFECT OF CARBON DIOXIDE IN ACUTE MOUNTAIN SICKNESS: A REDISCOVERY , 1988, The Lancet.

[92]  G. Lu,et al.  Role of Excitatory Amino Acids in Hypoxic Preconditioning , 1999, Neurosignals.

[93]  R. Wilson Acute high-altitude illness in mountaineers and problems of rescue. , 1973, Annals of internal medicine.

[94]  T. Maren,et al.  Carbonic anhydrase: chemistry, physiology, and inhibition. , 1967, Physiological reviews.

[95]  Hansen Je,et al.  A hypothesis regarding the pathophysiology of acute mountain sickness. , 1970 .

[96]  J. Anholm,et al.  Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial. , 2005, Archives of internal medicine.

[97]  Exercise exacerbates acute mountain sickness at simulated high altitude. , 2000 .

[98]  R. Wilber Live high + train low: thinking in terms of an optimal hypoxic dose. , 2007 .

[99]  D. Bailey,et al.  Acute mountain sickness; prophylactic benefits of antioxidant vitamin supplementation at high altitude. , 2001, High altitude medicine & biology.

[100]  A. Luks Which medications are safe and effective for improving sleep at high altitude? , 2008, High altitude medicine & biology.

[101]  E. Swenson Carbonic anhydrase inhibitors and ventilation: a complex interplay of stimulation and suppression. , 1998, The European respiratory journal.

[102]  Cyrill Burger,et al.  Changes of Cerebral Blood Flow during Short-Term Exposure to Normobaric Hypoxia , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[103]  R. M. Peters,et al.  Acetazolamide and exercise in sojourners to 6,300 meters--a preliminary study. , 1985, Medicine and science in sports and exercise.

[104]  S. Loft,et al.  Acute hypoxia and cytochrome P450–mediated hepatic drug metabolism in humans , 2002, Clinical pharmacology and therapeutics.

[105]  J. Rigg,et al.  Effect of acetazolamide on hypoxemia during sleep at high altitude. , 1979, The New England journal of medicine.

[106]  B. Basnyat,et al.  Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT) , 2004, BMJ : British Medical Journal.

[107]  J. Pandit Altitude induced illness. , 1992, BMJ.

[108]  Andries D. Bosch,et al.  Cerebral Autoregulation in Subjects Adapted and Not Adapted to High Altitude , 2000, Stroke.

[109]  J. Olesen,et al.  Plasma levels of substance P, neuropeptide Y and vasoactive intestinal polypeptide in patients with chronic tension-type headache , 1999, PAIN®.

[110]  V. Aoki,et al.  Body hydration and the incidence and severity of acute mountain sickness. , 1971, Journal of applied physiology.

[111]  P. Hackett,et al.  Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness. , 2008, High altitude medicine & biology.

[112]  K. Burgess,et al.  Acute mountain sickness is associated with sleep desaturation at high altitude , 2004, Respirology.

[113]  P. Bartsch,et al.  Acute mountain sickness: influence of susceptibility, preexposure, and ascent rate. , 2002, Medicine and science in sports and exercise.

[114]  H. Hautmann,et al.  Theophylline improves acute mountain sickness. , 2000, The European respiratory journal.

[115]  M. Moskowitz,et al.  High altitude headache. Lessons from headaches at sea level. , 1999, Advances in experimental medicine and biology.

[116]  P. Bärtsch,et al.  Comparison of carbon-dioxide-enriched, oxygen-enriched, and normal air in treatment of acute mountain sickness , 1990, The Lancet.

[117]  Jacob E. Barkley,et al.  Catecholamine levels in hypoxia-lnduced acute mountain sickness. , 2009, Aviation, space, and environmental medicine.

[118]  A. Richardson,et al.  Hydration and the Physiological Responses to Acute Normobaric Hypoxia , 2009, Wilderness & environmental medicine.

[119]  E. Swenson,et al.  Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial. , 2006, High altitude medicine & biology.

[120]  M. Maggiorini,et al.  Simulated descent v dexamethasone in treatment of acute mountain sickness: a randomised trial , 1995, BMJ.

[121]  R. Clayton,et al.  Medroxyprogesterone at High Altitude. The Effects on Blood Gases, Cerebral Regional Oxygenation, and Acute Mountain Sickness , 2004, Wilderness & environmental medicine.

[122]  P. Hackett,et al.  THE INCIDENCE, IMPORTANCE, AND PROPHYLAXIS OF ACUTE MOUNTAIN SICKNESS , 1976, The Lancet.

[123]  R L Burse,et al.  Procedures for the measurement of acute mountain sickness. , 1983, Aviation, space, and environmental medicine.

[124]  P. Hackett,et al.  Ginkgo biloba Does—and Does Not—Prevent Acute Mountain Sickness , 2009, Wilderness & environmental medicine.

[125]  W. Henderson,et al.  Leukotriene receptor blockade does not prevent acute mountain sickness induced by normobaric hypoxia. , 2007, High altitude medicine & biology.

[126]  A. Bradwell,et al.  EFFECT OF ACETAZOLAMIDE ON EXERCISE PERFORMANCE AND MUSCLE MASS AT HIGH ALTITUDE , 1986, The Lancet.

[127]  A. Young,et al.  Effect of spironolactone on acute mountain sickness. , 1986, Aviation, space, and environmental medicine.

[128]  D. Wagner,et al.  Reliability and utility of a visual analog scale for the assessment of acute mountain sickness. , 2007, High altitude medicine & biology.

[129]  G. Dubowitz Effect of temazepam on oxygen saturation and sleep quality at high altitude: randomised placebo controlled crossover trial , 1998, BMJ.

[130]  L. Moore,et al.  Low acute hypoxic ventilatory response and hypoxic depression in acute altitude sickness. , 1986, Journal of applied physiology.

[131]  R. C. Sawhney,et al.  Glucocorticoids as prophylaxis against acute mountain sickness , 2002, Clinical endocrinology.

[132]  P. Palange,et al.  Relationship between individual ventilatory response and acute renal water excretion at high altitude , 2008, Respiratory Physiology & Neurobiology.

[133]  Thomas G. Smith,et al.  The increase in pulmonary arterial pressure caused by hypoxia depends on iron status , 2008, The Journal of physiology.

[134]  Arthur R. Bradwell,et al.  Effect of sildenafil and acclimatization on cerebral oxygenation at altitude. , 2005, Clinical science.

[135]  E. Swenson,et al.  A dose-response study of acetazolamide for acute mountain sickness prophylaxis in vacationing tourists at 12,000 feet (3630 m). , 2004, High altitude medicine & biology.

[136]  Uwe Christians,et al.  Greater free plasma VEGF and lower soluble VEGF receptor-1 in acute mountain sickness. , 2005, Journal of applied physiology.

[137]  R. Roach,et al.  Acute mountain sickness and acetazolamide. Clinical efficacy and effect on ventilation. , 1982, JAMA.

[138]  P. Bärtsch,et al.  Enhanced cerebral blood flow in acute mountain sickness. , 1994, Aviation, space, and environmental medicine.

[139]  Thomas F. Hornbein,et al.  Cerebral Blood Flow In Man at High Altitude: Role of Cerebrospinal Fluid pH in Normalization of Flow in Chronic Hypocapnia , 1966, Circulation research.

[140]  M. Coleman,et al.  Hypoxia, hypoxia-inducible factors (HIF), HIF hydroxylases and oxygen sensing , 2009, Cellular and Molecular Life Sciences.

[141]  J. Launay,et al.  Prevention of acute mountain sickness by low positive end-expiratory pressure in field conditions. , 2004, Scandinavian journal of work, environment & health.

[142]  D. Leaf,et al.  Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness. , 2007, Journal of applied physiology.

[143]  Michael J. Taylor,et al.  Six percent oxygen enrichment of room air at simulated 5,000 m altitude improves neuropsychological function. , 2000, High altitude medicine & biology.

[144]  B. Kayser,et al.  Treatment of acute mountain sickness by simulated descent: a randomised controlled trial. , 1993, BMJ.

[145]  D. Webb,et al.  Oral antioxidant supplementation does not prevent acute mountain sickness: double blind, randomized placebo-controlled trial. , 2009, QJM : monthly journal of the Association of Physicians.

[146]  Masafumi Kitakaze,et al.  ER stress in cardiovascular disease. , 2010, Journal of molecular and cellular cardiology.

[147]  S. Salimi,et al.  Low-Dose Gabapentin in Treatment of High-Altitude Headache , 2007, Cephalalgia : an international journal of headache.

[148]  M. Sander,et al.  Sympathetic neural overactivity in healthy humans after prolonged exposure to hypobaric hypoxia , 2003, The Journal of physiology.

[149]  H. Hinghofer-Szalkay,et al.  Ventilation during simulated altitude, normobaric hypoxia and normoxic hypobaria. , 1997, Respiration physiology.

[150]  S. Kriemler,et al.  Successful treatment of acute mountain sickness with dexamethasone. , 1987, British medical journal.

[151]  K. Pattinson,et al.  Effect of exercise on cerebral perfusion in humans at high altitude. , 2005, Journal of applied physiology.

[152]  K. Kubo,et al.  Symptoms of acute mountain sickness in Sherpas exposed to extremely high altitude. , 2006, High altitude medicine & biology.

[153]  A. Dahan,et al.  Antioxidants reverse depression of the hypoxic ventilatory response by acetazolamide in man , 2006, The Journal of physiology.

[154]  P. Hackett,et al.  Arterial oxygen saturation for prediction of acute mountain sickness. , 1998, Aviation, space, and environmental medicine.

[155]  M. Brooks Methylene blue, an antidote to altitude sickness. , 1948, The Journal of aviation medicine.

[156]  K. Kallenberg,et al.  Magnetic Resonance Imaging Evidence of Cytotoxic Cerebral Edema in Acute Mountain Sickness , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[157]  Q. Pittman,et al.  Effects of acute hypoxia and hyperthermia on the permeability of the blood-brain barrier in adult rats. , 2009, Journal of applied physiology.

[158]  L. Ried,et al.  Acetazolamide or dexamethasone for prevention of acute mountain sickness: a meta-analysis , 1994 .

[159]  C. Houston,et al.  CEREBRAL FORM OF HIGH-ALTITUDE ILLNESS , 1975, The Lancet.

[160]  A. Cymerman,et al.  Dexamethasone as prophylaxis for acute mountain sickness. Effect of dose level. , 1989, Chest.

[161]  A. Cymerman,et al.  Exercise performance of sea-level residents at 4300 m after 6 days at 2200 m. , 2009, Aviation, space, and environmental medicine.

[162]  J. Maher,et al.  Prevention of acute mountain sickness by dexamethasone. , 1984, The New England journal of medicine.

[163]  G. Gray,et al.  Control of acute mountain sickness. , 1971, Aerospace medicine.

[164]  R. Huber,et al.  Theophylline and acetazolamide reduce sleep-disordered breathing at high altitude , 2004, European Respiratory Journal.

[165]  I. Spyridopoulos,et al.  Acute mountain sickness is not related to cerebral blood flow: a decompression chamber study. , 1999, Journal of applied physiology.

[166]  N. Voelkel,et al.  Plasma vascular endothelial growth factor in acute mountain sickness. , 2000, Chest.

[167]  Low-dose acetylsalicylic acid analog and acetazolamide for prevention of acute mountain sickness. , 2008, High altitude medicine & biology.

[168]  I. Singh,et al.  Acute mountain sickness. , 1969, The New England journal of medicine.

[169]  P. Hackett,et al.  Medical therapy of altitude illness. , 1987, Annals of emergency medicine.

[170]  R. I. Gamow,et al.  A self-contained life support system designed for use with a portable hyperbaric chamber. , 1989, Biomedical sciences instrumentation.

[171]  K. Strohl,et al.  Low-dose theophylline reduces symptoms of acute mountain sickness. , 2008, Journal of travel medicine.

[172]  C. W. Harris,et al.  Effects of altitude acclimatization on blood composition of women. , 1969, Journal of applied physiology.

[173]  S. Salimi,et al.  Sumatriptan for prevention of acute mountain sickness: randomized clinical trial , 2007, Annals of neurology.

[174]  M. A. Nerín,et al.  Acute Mountain Sickness: Influence of Fluid Intake , 2006, Wilderness & environmental medicine.

[175]  R. Panerai,et al.  Effects of Hypobaric Hypoxia on Cerebral Autoregulation , 2010, Stroke.

[176]  P. Curtis Letter: Medicine by remote control. , 1973, Lancet.

[177]  W. Schmidt,et al.  Long-term intermittent hypoxia increases O2-transport capacity but not VO2max. , 2007, High altitude medicine & biology.

[178]  W. Nachbauer,et al.  Aspirin for prophylaxis against headache at high altitudes: randomised, double blind, placebo controlled trial , 1998, BMJ.

[179]  J B West,et al.  Barometric pressures on Mt. Everest: new data and physiological significance. , 1999, Journal of applied physiology.